Close Menu

Missing From Trials

African-American patients are missing out on cancer drug clinical trial opportunities, Stat News and ProPublica report. Their analysis of US Food and Drug Administration data found that for most trials for cancer drugs approved since 2015, fewer than 5 percent of the patients who participated were African American, even as African Americans make up 13.4 percent of the US population.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.